Ads
related to: risk and empowerment in health care system cover hiv meds treatment research- Treatment Costs & Savings
See If You Are Eligible For Savings
Or Assistance Programs.
- HIV Treatment Injectable
Learn About A Treatment Option
And Find More Info Online Today.
- Helpful Patient Tools
Find Information For Patients Here.
Visit The Official Patient Website.
- Helpful Resources
Learn About An HIV Treatment
And Discover More About Dosing.
- Long-Acting HIV Treatment
Injections Just Every Other Month
With A Flexible Treatment Window.
- Get Treatment Resources
See Tools Specifically For Patients
About Dosing, Savings And More.
- Treatment Costs & Savings
Search results
Results From The WOW.Com Content Network
[citation needed] It is important to recognized that socioeconomic status, access to medical care, geographic location, public policy, race and ethnicity all play a pivotal role in the treatment and management of HIV/AIDS. The lack of sufficient and constant income does limit the options for food, treatment, and medications.
Initiation of post-exposure prophylaxis with the use of antiretroviral drugs is dependent on a number of risk factors, though treatment is usually started after one high-risk event. In order to determine whether post-exposure prophylaxis is indicated, an evaluation visit will be conducted to consider risk factors associated with developing HIV .
Research to improve current treatments includes decreasing side effects of current drugs, further simplifying drug regimens to improve adherence, and determining better sequences of regimens to manage drug resistance. There are variations in the health community in recommendations on what treatment doctors should recommend for people with HIV.
The abbreviation PrEP now typically refers to pre-exposure prophylaxis for HIV prevention, the use of antiviral drugs as a strategy for the prevention of HIV/AIDS. [2] PrEP is one of a number of HIV prevention strategies for people who are HIV negative but who have a higher risk of acquiring HIV, including sexually active adults at increased risk of contracting HIV, people who engage in ...
[9] [2] Individuals must test negative for HIV prior to PrEP initiation because persons infected with HIV taking PrEP medication are at risk for becoming resistant to emtricitabine. Consequently, people with HIV infection and resistance to emtricitabine will have fewer options for selecting HIV treatment medications. [10]
The study enrolled adult patients with the disease whose viral load - the amount of HIV in the blood - was suppressed to undetectable levels by antiretroviral therapy (ART).
Ads
related to: risk and empowerment in health care system cover hiv meds treatment research